{"entity":{"type":"insider","cik":"0001509563","url":"/insider/0001509563","json_url":"/insider/0001509563.json","name":"Giffoni Kim","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":6,"first":"2013-12-04","last":"2015-11-24","span_basis":"filed_date"},"name_variants":[{"name":"Giffoni Kim","source":"filing","n_filings":6,"first_seen":"2013-12-04","last_seen":"2015-11-24"}],"transactions":[{"id":8623434,"accession":"0001493152-15-005866","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-15-005866","line_url":"/filing/0001493152-15-005866#line-1","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Giffoni Kim; Giffoni Olena B.; Giffoni Family Trust Dated September 26 2008","owner_display_name":"Giffoni Kim","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8580.0,"shares_display":"8,580","price_per_share":0.015,"price_display":"0.02","price_state":"stated","total_value":128.7,"total_display":"128.70","total_whole":"129","shares_owned_after":2646668.0,"shares_owned_after_display":"2,646,668","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-24","filed_date":"2015-11-24","scope":"insider"},{"id":6921401,"accession":"0001493152-14-003930","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-14-003930","line_url":"/filing/0001493152-14-003930","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":null,"owner_name":"Giffoni Family Trust Dated September 26 2008; Giffoni Kim; Giffoni Olena B.","owner_display_name":"Giffoni Family Trust Dated September 26 2008","owner_url":null,"role":"Director, Officer (EVP Foreign Sales/Inv. Rel), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"EVP Foreign Sales/Inv. Rel.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":350.0,"total_display":"350.00","total_whole":"350","shares_owned_after":2655048.0,"shares_owned_after_display":"2,655,048","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-24","scope":"insider","n_lines":2},{"id":7022500,"accession":"0001493152-14-001085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-14-001085","line_url":"/filing/0001493152-14-001085","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001509563","owner_name":"Giffoni Kim","owner_display_name":"Giffoni Kim","owner_url":"/insider/0001509563","role":"Director, Officer (EVP Foreign Sales/Inv. Rel), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Foreign Sales/Inv. Rel.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.834,"price_display":"0.83","price_state":"stated","total_value":4170.0,"total_display":"4,170.00","total_whole":"4,170","shares_owned_after":76021.0,"shares_owned_after_display":"76,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-09","filed_date":"2014-04-10","scope":"insider","n_lines":2},{"id":5385798,"accession":"0001144204-13-067548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-067548","line_url":"/filing/0001144204-13-067548#line-1","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001509563","owner_name":"Giffoni Kim","owner_display_name":"Giffoni Kim","owner_url":"/insider/0001509563","role":"Director, Officer (EVP Foreign Sales/Inv. Rel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Foreign Sales/Inv. Rel.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":900.0,"total_display":"900.00","total_whole":"900","shares_owned_after":71021.0,"shares_owned_after_display":"71,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-12","filed_date":"2013-12-16","scope":"insider"},{"id":5160020,"accession":"0001144204-13-066784","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-13-066784","line_url":"/filing/0001144204-13-066784#line-3","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001509563","owner_name":"Giffoni Kim","owner_display_name":"Giffoni Kim","owner_url":"/insider/0001509563","role":"Director, Officer (EVP Foreign Sales/Inv. Rel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Foreign Sales/Inv. Rel.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":880.0,"total_display":"880.00","total_whole":"880","shares_owned_after":70021.0,"shares_owned_after_display":"70,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-11","filed_date":"2013-12-11","scope":"insider"},{"id":5160014,"accession":"0001144204-13-066784","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-066784","line_url":"/filing/0001144204-13-066784#line-2","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001509563","owner_name":"Giffoni Kim","owner_display_name":"Giffoni Kim","owner_url":"/insider/0001509563","role":"Director, Officer (EVP Foreign Sales/Inv. Rel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Foreign Sales/Inv. Rel.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7480.0,"shares_display":"7,480","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":6732.0,"total_display":"6,732.00","total_whole":"6,732","shares_owned_after":69021.0,"shares_owned_after_display":"69,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-10","filed_date":"2013-12-11","scope":"insider"},{"id":5160001,"accession":"0001144204-13-066784","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-066784","line_url":"/filing/0001144204-13-066784#line-1","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001509563","owner_name":"Giffoni Kim","owner_display_name":"Giffoni Kim","owner_url":"/insider/0001509563","role":"Director, Officer (EVP Foreign Sales/Inv. Rel)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Foreign Sales/Inv. Rel.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":0.83,"price_display":"0.83","price_state":"stated","total_value":2905.0,"total_display":"2,905.00","total_whole":"2,905","shares_owned_after":61541.0,"shares_owned_after_display":"61,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-09","filed_date":"2013-12-11","scope":"insider"},{"id":5016735,"accession":"0001144204-13-065520","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-13-065520","line_url":"/filing/0001144204-13-065520#line-3","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001509563","owner_name":"Giffoni Kim","owner_display_name":"Giffoni Kim","owner_url":"/insider/0001509563","role":"Director, Officer (EVP Foreign Sales/Inv. Rel), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Foreign Sales/Inv. Rel.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":1785.0,"total_display":"1,785.00","total_whole":"1,785","shares_owned_after":58041.0,"shares_owned_after_display":"58,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":5016724,"accession":"0001144204-13-065520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-065520","line_url":"/filing/0001144204-13-065520#line-2","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001509563","owner_name":"Giffoni Kim","owner_display_name":"Giffoni Kim","owner_url":"/insider/0001509563","role":"Director, Officer (EVP Foreign Sales/Inv. Rel), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Foreign Sales/Inv. Rel.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":1.09,"price_display":"1.09","price_state":"stated","total_value":654.0,"total_display":"654.00","total_whole":"654","shares_owned_after":56341.0,"shares_owned_after_display":"56,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-29","filed_date":"2013-12-04","scope":"insider"},{"id":5016717,"accession":"0001144204-13-065520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-065520","line_url":"/filing/0001144204-13-065520#line-1","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001509563","owner_name":"Giffoni Kim","owner_display_name":"Giffoni Kim","owner_url":"/insider/0001509563","role":"Director, Officer (EVP Foreign Sales/Inv. Rel), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Foreign Sales/Inv. Rel.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.06,"price_display":"1.06","price_state":"stated","total_value":2650.0,"total_display":"2,650.00","total_whole":"2,650","shares_owned_after":55741.0,"shares_owned_after_display":"55,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-27","filed_date":"2013-12-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001420030","name":"Targeted Medical Pharma, Inc.","url":"/issuer/0001420030","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":6,"first_seen":"2013-12-04","last_seen":"2015-11-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001509563","retrieved_at":"2026-08-24T04:05:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}